STING inhibitors target the cyclic dinucleotide binding pocket
Cytosolic DNA activates cGAS (cytosolic DNA sensor cyclic AMP-GMP synthase)-STING (stimulator of interferon genes) signaling, which triggers interferon and inflammatory responses that help defend against microbial infection and cancer. However, aberrant cytosolic self-DNA in Aicardi–Goutière’s syndr...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 118; no. 24; pp. 1 - 10 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Washington
National Academy of Sciences
15.06.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Cytosolic DNA activates cGAS (cytosolic DNA sensor cyclic AMP-GMP synthase)-STING (stimulator of interferon genes) signaling, which triggers interferon and inflammatory responses that help defend against microbial infection and cancer. However, aberrant cytosolic self-DNA in Aicardi–Goutière’s syndrome and constituently active gain-of-function mutations in STING in STING-associated vasculopathy with onset in infancy (SAVI) patients lead to excessive type I interferons and proinflammatory cytokines, which cause difficult-to-treat and sometimes fatal autoimmune disease. Here, in silico docking identified a potent STING antagonist SN-011 that binds with higher affinity to the cyclic dinucleotide (CDN)-binding pocket of STING than endogenous 2′3′-cGAMP. SN-011 locks STING in an open inactive conformation, which inhibits interferon and inflammatory cytokine induction activated by 2′3′-cGAMP, herpes simplex virus type 1 infection, Trex1 deficiency, overexpression of cGAS-STING, or SAVI STING mutants. In Trex1
−/− mice, SN-011 was well tolerated, strongly inhibited hallmarks of inflammation and autoimmunity disease, and prevented death. Thus, a specific STING inhibitor that binds to the STING CDN-binding pocket is a promising lead compound for STING-driven disease. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 1Z.H., J.M., and C.L. contributed equally to this work. Reviewers: H.-B.S., Wuhan University; and N.Y., University of Texas Southwestern Medical Center. Author contributions: Z.H., J.M., C.L., J.L., and C.W. designed research; Z.H., J.M., C.L., J.L., and C.W. performed research; Z.H. and J.M. conducted surface plasmon resonance experiments; Z.H., J.M., and M.M. performed in vivo animal experiments; Z.H. and C.W. designed the compounds; L.S., Y.Y., and H.S. participated in chemical synthesis; Z.H., J.M., and H.H. performed RNA-sequencing experiments and analysis; W.Y. and Y.L. performed the docking screen; G.B., L.Z., D.C., S.L., and J.H. assisted in experiments; J.L. analyzed data; and Z.H., J.M., X.L., J.L., and C.W. wrote the paper. Contributed by Judy Lieberman, May 6, 2021 (sent for review March 22, 2021; reviewed by Hong-Bing Shu and Nan Yan) |
ISSN: | 0027-8424 1091-6490 1091-6490 |
DOI: | 10.1073/pnas.2105465118 |